Has Matthew Alexander, MD received payments from drug or device companies?

Yes. Drug and device makers reported $435,256 in general payments to Matthew Alexander, MD across 66 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Matthew Alexander, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Matthew Alexander, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Matthew Alexander, MD

Vascular & Interventional Radiology · Sacramento, CANPI 1578899662

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $425,728 of the $435,256 with a category attached, or 97.8%. Route 92 Medical, Inc. accounts for 95.9% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $308,881, more than ten times the $3,923 reported in 2019. Among vascular & interventional radiology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$435,256in general payments, 2019–2025

Across 66 payments — averaging $6594.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Route 92 Medical, Inc.$417K
Medical Device Business Services, Inc.$10K
Microvention, Inc.$2K
Stryker$2K
Insightec,inc$1K
Medtronic$1K
plus $2K from 9 others

$38,664in ownership & investment interests, 2019–2025

Across 2 payments — averaging $19,332 each. An ownership or investment interest held by the physician or an immediate family member.

Route 92 Medical, Inc.$39K

What the payments were for

Consulting fees$425,72898%
Speaking & faculty fees$7470%
Travel & lodging$3,8931%
Food & beverage$4,8881%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Route 92 Medical, Inc.	6	$417,496
Medical Device Business Services, Inc.	2	$9,675
Microvention, Inc.	14	$2,363
Stryker	11	$1,533
Insightec,inc	1	$1,352
Medtronic(2 entities)	7	$1,236
Johnson & Johnson	10	$684
Biosense Webster, Inc.	3	$303
Imperative Care, Inc	5	$200
Rapid Medical Ltd	1	$144
Penumbra, Inc.	2	$76
Siemens Medical Solutions USA, Inc.	1	$66
Qapel Medical Inc	1	$53
Balt USA, LLC	1	$48
Boston Scientific	1	$26

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

8F Base Camp Sheath System$110,181
HIPOINT 088$109,427
WEB$1,754
Pipeline$1,013
PROWLER$342
Embotrap$225
BROADWAY 8$151
EMBOTRAP II Revascularization Device$148
WEB Aneurysm Embolization System$148
STENT$148
SOFIA 6F-131CM STR$148
TIGERTRIEVER 17 REVASCULARIZATION DEVICE$144
COMANECI 17$144
Scepter XC Balloon Catheter$142
LVIS Jr.$142
Headway Duo Microcatheter$142
Sofia$142
Reveal LINQ$132
Scepter C Balloon Catheter$108
TARGET$100

How this compares

$435,256 in reported general payments places this provider in the 95th percentile of 504 vascular & interventional radiology providers in California.

See all vascular & interventional radiology providers in California →

Medicare billing

Part B allowed, 2024

$466,284

Medicare patients

1,837

Services billed

30,877

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
ClopidogrelClopidogrel Bisulfate	34	$308
Pantoprazole Sodium	30	$277

Paid to pharmacies, not to this prescriber.

Other vascular & interventional radiology in Sacramento

Christopher LaingSacramento$124K
Patrick HartySacramento$118K
Mahmood RazaviOrange$2.4M
Keith TerasakiLos Angeles$1.7M
Bart DolmatchMountain View$1.7M
Edward LeeLos Angeles$1.4M
Alexander MisonoNewport Beach$1.3M
Kevin BurnsOrange$1.1M
Siddharth PadiaLos Angeles$960K
Satoshi TateshimaLos Angeles$764K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →